Professor Melissa Southey
Research Director, MPCCC; Chair of Precision Medicine, School of Clinical Sciences at Monash Health; Director, Biobanking Victoria, Monash University.
Professor Melissa Southey is a molecular geneticist (FHGSA), a Founding Fellow of the Faculty of Science, Royal College of Pathologists of Australasia (FFSc, RCPA), and is a National Health and Medical Research Council (NHMRC) Research Fellow. Professor Southey is best known for her work with multiple-case cancer families and heritable risk factors. Her research has provided the evidence base for best practice guidelines for clinical management of individuals at high risk of cancer. She leads multidisciplinary teams in diagnostic and research settings in Australia and internationally.
Professor Roger Daly
Workforce and Education Director, MPCCC; Head, Department of Biochemistry and Molecular Biology, Monash University.
Professor Daly is an internationally recognised expert in growth factor receptor signaling and its deregulation in cancer. Over the last 5 years he has established cutting-edge technology platforms in mass spectrometry-based proteomics and kinomics. These have been successfully applied to the characterisation of cancer signaling networks with the goal of identifing novel therapeutic targets and biomarkers.
Professor Eva Segelov
Professor and Director of Oncology, Monash Health and Monash University.
Professor Eva Segelov is a recognised national and international expert in the fields of gastrointestinal cancer, neuroendocrine tumours, and breast cancer, with a 20 year history of management of patients in a multidisciplinary setting. Professor Segelov has led multiple national and international oncology clinical trials, including investigator-initiated studies. Her research interests relate to translational studies of targeted therapies in defined subpopulations to increase benefit and reduce the toxicity of cancer treatments.
Professor John Zalcberg OAM
Monash Partners Cancer and Blood Diseases Theme Representative; Head, Cancer Research Program, School of Public Health and Preventive Medicine, Monash University; Tony Charlton Chair of Oncology, Alfred Health.
Professor Zalcberg’s clinical research interests include gastrointestinal cancer and health care outcomes. He leads projects in Clinical Quality Registries that collect patient outcome data for lung, ovarian and Upper Gastrointestinal cancers. He has an active involvement in clinical trials in GI cancers and continues an active clinical practice in GI cancer. Professor John Zalcberg was the Director, Division of Cancer Medicine, at the Peter MacCallum Cancer Centre in Melbourne, Australia for 17 years prior to recently taking up the position.
Associate Professor Zee Wan Wong
Joint Clinical Director, Southern Melbourne Integrated Cancer Service; Head of Oncology, Peninsula Health; Adjunct Clinical Associate Professor, Monash University; Senior Lecturer, University of Melbourne Medical School, Department of Rural Health.
Dr Wong’s clinical focus includes breast and gastrointestinal cancers as well as immunotherapy. Dr Wong has an active interest in clinical research and teaching, and is working towards expanding the oncology service, clinical trials and survivorship initiatives at Peninsula Health. In her role as joint SMICS Clinical Director, Dr Wong aims to contribute to the implementation and evaluation of the Optimal Care Pathways.
Dr Andrew Haydon
Joint Clinical Director, Southern Melbourne Integrated Cancer Service; Medical Oncologist, Alfred Health.
Dr Haydon’s clinical interests are in the treatment of melanoma, head and neck cancer, and gastro-intestinal malignancies. He has been the Principal investigator in over 40 clinical trials and has authored or co-authored over 50 peer reviewed publications. As SMICS joint Clinical Director Dr Haydon will adopt a leading role in the improvement of oncology service delivery and referral pathways.
Ms Anna Kilgour
Chief Operating Officer, MPCCC.
Anna Kilgour has worked to establish cancer collaborations and transformational research programs across the Monash partnership since 2011. As COO Anna facilitates MPCCC’s governance mechanisms, partnerships and collaborations and is responsible for program reporting and planning, operational implementation and program management, communications and events.
Ms Seleena Sherwell
Program Manager, Southern Melbourne Integrated Cancer Service.
Seleena holds a Bachelor of Applied Science (Psychology), a Diploma of Project Management and a Vocational Graduate Certificate in Consumer Engagement. She has worked to establish programs at the Southern Melbourne Integrated Cancer Service that improve equity and accessibility of cancer services in southern Melbourne, and provided critical guidance and support for cancer service implementation programs.